WO2021184410A2 - 一种非接触式的心血管健康评估方法 - Google Patents
一种非接触式的心血管健康评估方法 Download PDFInfo
- Publication number
- WO2021184410A2 WO2021184410A2 PCT/CN2020/081533 CN2020081533W WO2021184410A2 WO 2021184410 A2 WO2021184410 A2 WO 2021184410A2 CN 2020081533 W CN2020081533 W CN 2020081533W WO 2021184410 A2 WO2021184410 A2 WO 2021184410A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beat
- data
- bcg
- ecg
- assessment method
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 35
- 230000036996 cardiovascular health Effects 0.000 title claims description 18
- 238000013526 transfer learning Methods 0.000 claims description 18
- 238000012360 testing method Methods 0.000 claims description 14
- 238000004422 calculation algorithm Methods 0.000 claims description 12
- 230000000747 cardiac effect Effects 0.000 claims description 9
- 238000013508 migration Methods 0.000 claims description 9
- 230000005012 migration Effects 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 238000012549 training Methods 0.000 claims description 8
- 230000002159 abnormal effect Effects 0.000 claims description 4
- 238000007781 pre-processing Methods 0.000 claims description 4
- 238000003066 decision tree Methods 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 2
- 238000013507 mapping Methods 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 230000005189 cardiac health Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000001013 sinoatrial node Anatomy 0.000 description 2
- 101150085275 Colec12 gene Proteins 0.000 description 1
- 102100024330 Collectin-12 Human genes 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 101001137525 Homo sapiens Nucleolin Proteins 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 102100021010 Nucleolin Human genes 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 238000013145 classification model Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002182 neurohumoral effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1102—Ballistocardiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
Definitions
- the invention relates to the medical field, in particular to a non-contact cardiovascular health assessment method.
- Cardiovascular diseases have severely affected people's lives and health. As of 2018, there are 290 million patients with cardiovascular diseases in China, and the prevalence rate is on the rise. Therefore, daily monitoring, evaluation and disease diagnosis of cardiovascular health are of great significance.
- ECG Electrocardiogram
- impedance electrocardiogram impedance electrocardiogram
- echocardiogram echocardiogram
- phonocardiogram phonocardiogram
- Ballistocardiogram is a non-invasive, non-contact monitoring method of cardiovascular function. It is mainly caused by the change of the body's gravity caused by the blood circulation process. Compared with other cardiovascular detection technologies, it has the advantages of non-invasive, no direct contact and convenient detection, and is particularly suitable for long-term monitoring.
- Heart Rate Variability arises from the regulation of the heart's sinus node by the autonomic nervous system, which reflects the degree of sinus arrhythmia in the heart itself and the balance of the interaction between neurohumoral factors and the sinus node.
- the present invention provides a non-contact cardiovascular health assessment method for non-contact auxiliary diagnosis of the user's heart condition.
- a non-contact cardiovascular health assessment method of the present invention includes the following steps: S101: data acquisition and preprocessing; S102: extracting HRV features; S103: designing a transfer learning classifier to test the data.
- the S101 includes the following steps: S1011: collect user's BCG data, download ECG data from the database; S1012: unmix the BCG data, and remove noise from the ECG; S1013: calculate the beat cycle of the BCG data , Calculate the beat-by-beat heart cycle of ECG data; S1014: Remove the abnormal value of the beat-by-beat heart cycle of the BCG data and the beat-by-beat heart cycle of the ECG data.
- the S102 includes the following steps: S1021: Extract HRV time domain features from the BCG data beat-by-beat heart cycle and ECG data beat-by-beat heart cycle; S1022: Extract the beat-by-beat heart cycle from the BCG data and the beat-by-beat heart cycle from the ECG data HRV frequency domain features; S1023: extract HRV nonlinear features from BCG data beat-by-beat cardiac cycle and ECG data beat-by-beat cardiac cycle; S1024: normalize and filter the time-domain, frequency-domain and nonlinear features of HRV.
- the S103 includes the following steps: S1031: setting the parameters of the classifier; S1032: dividing the time domain feature, frequency domain feature, and nonlinear feature of BCG into training set and test set; dividing the time domain feature of ECG, Frequency domain features and nonlinear features are passed into the transfer learning model; S1033: Use the test set of BCG time domain features, frequency domain features and nonlinear features to test; adjust the classifier parameters twice.
- an IIR filter is used in S1012 for signal unmixing and noise removal.
- the template matching method is used to calculate the BCG signal beat-by-beat heart rate
- the PT algorithm is used to calculate the ECG beat-by-beat heart rate.
- the type of the classifier is a decision tree or SVM, and the number of iterations N of the classifier is 50.
- the training set and the test set are distributed at a ratio of 4:1 in a random manner.
- a non-contact cardiovascular health assessment method provided by the present invention utilizes the homology between BCG and ECG, and uses a transfer learning method to extract useful information from massive ECG databases for classifying BCG data Discrimination can be used for daily monitoring, evaluation and tracking of the user's heart health status, and it provides a feasible solution for BCG-based heart rate variability analysis for daily health evaluation.
- FIG. 1 is a flowchart of the present invention
- FIG. 2 is an effect diagram of collecting a BCG signal diagram and using a template matching algorithm to mark characteristic points according to an embodiment of the present invention.
- FIG. 3 is an ECG signal diagram of a database provided by an embodiment of the present invention and an effect diagram of marking characteristic points using a PT algorithm.
- Fig. 4 is a block diagram of Tradaboost migration learning provided by an embodiment of the present invention.
- This embodiment provides a non-contact cardiovascular health assessment method, as shown in FIG. 1, including the following steps: S101: data acquisition and preprocessing; S102: extracting HRV features; S103: designing a transfer learning classifier for data carry out testing.
- step S101 the specific operation is step S1011: collecting user BCG data.
- the existing methods such as optical fiber, piezoelectric ceramics, piezoelectric film or video, millimeter wave radar, etc. are used to obtain BCG signals of patients with cardiovascular diseases and samples of healthy people in resting state for more than 20 minutes.
- a piezoelectric ceramic sensor placed under the mattress is specifically used to collect 50 BCG sample data of cardiovascular disease patients and healthy people, each sample is 30 minutes, and the piezoelectric ceramic sensor model is not limited.
- download the ECG data from the database specifically download the original ECG data with sample tags (that is, with tags for cardiovascular disease patients and healthy people) from a public data set with certain authority.
- the downloaded disease samples and healthy samples should have the same amount of data as possible, the number of sample cases should be more than 50 cases, and the total data time should be greater than 50 hours.
- five data sets including NSR1, NSR2, INCART, SHAREE, and CHF in the Physionet database are selected to download data of a total of 116 hours of data of 50 samples of cardiovascular disease patients and healthy people.
- step S1012 signal unmixing of the collected BCG data, and noise removal of the downloaded ECG.
- the BCG signal uses an IIR filter for signal unmixing, which filters out breathing components and noise components in the BCG signal by using an IIR filter with a suitable passband frequency, leaving a purer heartbeat vibration in the BCG Ingredients.
- IIR filters include wavelet decomposition, empirical mode decomposition and so on.
- a 6th-order Butterworth bandpass filter with a passband frequency of 8-24 Hz is selected to filter the BCG.
- the ECG signal uses an IIR filter to remove noise, which is to use an IIR filter with a suitable frequency to remove noise and baseline drift in the ECG signal to obtain a higher quality ECG signal.
- IIR filters include moving average filtering, wavelet decomposition, and so on.
- a 0.2Hz-45Hz 6th-order Butterworth filter is selected to filter the ECG to remove noise.
- step S1013 the template matching method is used to calculate the beat-by-beat heart cycle of the BCG signal, and the PT algorithm is used to calculate the beat-by-beat heart cycle of the ECG.
- the template matching method in the prior art is used to calculate the beat-by-beat heart cycle of the BCG signal. Specifically, the template matching method is used to find the characteristic points of the BCG signal, and then the heartbeat cycle is calculated in combination with the sampling frequency.
- FIG. 2 shows the effect of using template matching to mark the J wave position of the BCG in this embodiment, that is, the BCG signal beats the heartbeat cycle.
- Template matching is an idea of using a template to compare and calculate the similarity with the object to be processed. It is often used for image similarity detection in image processing, it is often used for image similarity comparison, and it is also used in the field of signal processing to detect signal waveform similarity.
- the initial BCG signal is used to generate a template, and then the template is used to compare with the template generated later (the template generated by the BCG signal collected later). The process of this comparison is template matching.
- the above J wave position is the position of the marked point on the horizontal axis of time in FIG. 2.
- Using the PT algorithm to calculate the ECG beat-by-beat heart cycle is through the steps of band-pass filtering, differentiation, square, sliding window integration of the PT algorithm, and more accurately marks the R wave position of each beat.
- Figure 3 shows the effect of using the PT algorithm to mark the R wave position of the ECG in this embodiment, and the interval between adjacent R waves is the ECG beat-by-beat cardiac cycle.
- the PT algorithm is a particularly commonly used signal processing algorithm for marking R points in ECG processing.
- the PT algorithm is disclosed in the wearable ECG signal-based nervousness discrimination method and system thereof in Patent Publication No. CN109770920A.
- the above-mentioned R wave position is the position of the marked point on the horizontal axis of time in FIG. 3.
- Step S1014 Remove abnormal values in the beat-by-beat cardiac cycle of BCG and ECG, the removal method is 3 ⁇ principle, box diagram analysis, etc., to remove abnormal value points of the cardiac cycle caused by detection errors or occurrence of premature beats. So that the heart rate variability can be calculated later.
- This embodiment adopts the 3 ⁇ principle: in the normal distribution, ⁇ represents the standard deviation, and ⁇ represents the mean value.
- the probability that the value is distributed in ( ⁇ - ⁇ , ⁇ + ⁇ ) is 0.6826
- the probability that the value is distributed in ( ⁇ -2 ⁇ , ⁇ +2 ⁇ ) is 0.9544
- the probability that the value is distributed in ( ⁇ -3 ⁇ , ⁇ +3 ⁇ ) It can be considered that the value of the beat-by-beat cardiac cycle of BCG and ECG is almost all concentrated in the interval of ( ⁇ -3 ⁇ , ⁇ +3 ⁇ )], and the possibility of exceeding this range is only less than 0.3%. Out of this range is an outlier.
- Step S102 includes the following steps:
- Step S1021 Extracting the HRV time-domain features from the beat-by-beat heart cycles of BCG and ECG refers to extracting the HRV time-domain features from the BCG and ECG beat-by-beat heart cycles calculated in step S101.
- the methods of extracting HRV time-domain features include average, standard deviation, root mean square deviation, peak value, median, and standard deviation of difference.
- the method of extracting the HRV frequency domain features may be to find the power of each frequency segment of the beat-by-beat cardiac cycle sequence.
- step S1023 the method of extracting the non-linear characteristics of the HRV is to find the axis length of the Poincaré diagram, the sympathetic index and various entropy values.
- Normalization is a way to simplify calculations, that is, a dimensional expression is transformed into a non-dimensional expression and becomes a scalar.
- Step S103 includes the following steps:
- Step S1031 Setting the parameters of the transfer learning classifier refers to setting some hyperparameters of the transfer learning classifier.
- the types of transfer learning models include feature mapping transfer learning models, sample weight transfer learning models, and so on. This embodiment adopts Tradaboost, a classifier for sample weight migration:
- the hyperparameters are respectively set as follows: the type of base classifier is decision tree or SVM, and the number of iterations N is 50 (the value can be adjusted according to the situation).
- Step S1032 The HRV features of BCG are randomly divided into training set (source domain training data) and test set at 4:1, and the HRV feature training set of BCG is passed into the migration learning classifier as the target domain feature of the migration learning classifier.
- the HRV feature (auxiliary domain training data) of ECG is transferred to the migration learning model as the auxiliary domain feature of the migration learning classifier.
- the advantage of using the HRV feature calculated in the ECG as the auxiliary domain feature is that learning from ECG data with a large amount of data helps to improve the classification accuracy and generalization ability of the target domain data, so as to improve the performance of the classifier.
- Step S1033 Train the transfer learning classifier and use the HRV test set of the BCG for testing, and perform secondary adjustment on the parameters of the transfer learning classifier to generate the final classifier.
- the overall step flow chart of the present invention is shown in FIG. 1, and the transfer learning flow chart corresponding to the step flow chart of the present invention is shown in FIG. 4.
- the Tradaboost classifier used in this embodiment is modified from the Adaboost algorithm, a Boosting ensemble learning classification model.
- the sample data is reduced to adjust the weight using the following formula:
- ⁇ t ⁇ t /(1- ⁇ t )
- ⁇ t and ⁇ are the weight adjustment coefficients used for the target domain sample and the auxiliary domain sample
- ⁇ t is the error rate of the classifier in the target domain in the previous iteration
- n is the number of target domain samples
- N is the total iteration frequency.
- I the weight of the i-th sample in the t-th iteration.
- h t (x i ) and c(x i ) are the estimated value of the i-th sample by the classifier and its actual value, and the value is 1 or 0.
- BCG samples to be classified For new BCG samples to be detected (ie, BCG samples to be classified), preprocessing and feature extraction are performed, and a classifier is used to classify them.
- the classifier trained using migration learning can be used to classify the HRV calculated from BCG data.
- the steps for calculating HRV from BCG are shown in S101 and S102.
- the HRV features calculated from the BCG data to be classified are input into the classifier model, and the classifier model outputs the discriminant results: cardiovascular disease samples, healthy samples, and estimates of credibility.
- the non-contact cardiovascular health assessment method of the present invention extracts HRV features from the existing BCG and ECG signals respectively, and then builds a model through the transfer learning classifier, and the BCG and ECG signals of the patient to be tested are input into the transfer learning classifier , After the migration learning classifier produces health discrimination results, the detection is convenient and the result accuracy is high.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Signal Processing (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Evolutionary Computation (AREA)
- Mathematical Physics (AREA)
- Fuzzy Systems (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Power Engineering (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Description
Claims (9)
- 一种非接触式的心血管健康评估方法,其特征在于,包括以下步骤:S101:数据获取及预处理;S102:提取HRV特征;S103:设计迁移学习分类器对数据进行测试。
- 根据权利要求1所述的一种非接触式的心血管健康评估方法,其特征在于,所述S101中包括以下步骤:S1011:采集用户的BCG数据,从数据库下载ECG数据;S1012:将BCG数据进行信号解混,将ECG进行噪音去除;S1013:计算BCG数据逐拍心动周期,计算ECG数据逐拍心动周期;S1014:去除BCG数据逐拍心动周期和ECG数据逐拍心动周期的异常值。
- 根据权利要求1所述的一种非接触式的心血管健康评估方法,其特征在于,所述S102中包括以下步骤:S1021:从BCG数据逐拍心动周期、ECG数据逐拍心动周期提取HRV时域特征;S1022:从BCG数据逐拍心动周期、ECG数据逐拍心动周期提取HRV频域特征;S1023:从BCG数据逐拍心动周期、ECG数据逐拍心动周期提取HRV非线性特征;S1024:对HRV的时域特征、频域特征和非线性特征进行归一化和筛选。
- 根据权利要求3所述的一种非接触式的心血管健康评估方法,其特征在于,所述S103中包括以下步骤:S1031:设置分类器的参数;S1032:将BCG的时域特征、频域特征和非线性特征分为训练集和测试集;将ECG的时域特征、频域特征和非线性特征传入迁移学习模型;S1033:使用BCG的时域特征、频域特征和非线性特征的测试集进行测试;对分类器参数二次调参。
- 根据权利要求2所述的一种非接触式的心血管健康评估方法,其特征在于,在S1012中使用IIR滤波器进行信号解混和噪音去除。
- 根据权利要求2所述的一种非接触式的心血管健康评估方法,其特征在于,在S1013中,使用模板匹配法计算BCG信号逐拍心率,使用PT算法计算ECG逐拍心率。
- 根据权利要求4所述的一种非接触式的心血管健康评估方法,其特征在于,在S1031中,分类器的种类为决策树或者SVM。
- 根据权利要求4所述的一种非接触式的心血管健康评估方法,所述迁移学习模型为特征映射迁移学习模型、样本权重迁移学习模型。
- 根据权利要求4所述的一种非接触式的心血管健康评估方法,其特征在于,在S1032中,采用随机的方式将训练集和测试集按4:1的比例分配。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010191926.9 | 2020-03-18 | ||
CN202010191926.9A CN111329455A (zh) | 2020-03-18 | 2020-03-18 | 一种非接触式的心血管健康评估方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021184410A2 true WO2021184410A2 (zh) | 2021-09-23 |
Family
ID=71174685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/081533 WO2021184410A2 (zh) | 2020-03-18 | 2020-03-27 | 一种非接触式的心血管健康评估方法 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN114010171B (zh) |
WO (1) | WO2021184410A2 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429284A (zh) * | 2022-09-16 | 2022-12-06 | 山东科技大学 | 心电信号分类方法、系统、计算机设备以及可读存储介质 |
CN116211315A (zh) * | 2023-04-10 | 2023-06-06 | 济南大学 | 一种单导联心电信号辅助诊断方法及诊断终端 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112336310B (zh) * | 2020-11-04 | 2024-03-08 | 吾征智能技术(北京)有限公司 | 一种基于fcbf和svm融合的心脏疾病诊断系统 |
CN113420624B (zh) * | 2021-06-11 | 2022-04-26 | 华中师范大学 | 一种非接触式疲劳检测方法及系统 |
CN113413163B (zh) * | 2021-08-24 | 2021-11-19 | 山东大学 | 一种混合深度学习和低差异度森林的心音诊断系统 |
CN114052692B (zh) * | 2021-10-26 | 2024-01-16 | 珠海脉动时代健康科技有限公司 | 基于毫米波雷达的心率分析方法及设备 |
CN114995772B (zh) * | 2022-08-08 | 2022-10-21 | 南京三百云信息科技有限公司 | 客户数据迁移存储方法及装置 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109567780B (zh) * | 2018-12-07 | 2021-01-15 | 中国科学院电子学研究所 | 逐拍心率计算方法、装置、电子设备及存储介质 |
CN110148466B (zh) * | 2019-05-15 | 2022-11-25 | 东北大学 | 一种基于迁移学习的心冲击信号房颤计算机辅助诊断方法 |
-
2020
- 2020-03-18 CN CN202110675572.XA patent/CN114010171B/zh active Active
- 2020-03-18 CN CN202010191926.9A patent/CN111329455A/zh active Pending
- 2020-03-27 WO PCT/CN2020/081533 patent/WO2021184410A2/zh active Application Filing
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429284A (zh) * | 2022-09-16 | 2022-12-06 | 山东科技大学 | 心电信号分类方法、系统、计算机设备以及可读存储介质 |
CN115429284B (zh) * | 2022-09-16 | 2024-05-03 | 山东科技大学 | 心电信号分类方法、系统、计算机设备以及可读存储介质 |
CN116211315A (zh) * | 2023-04-10 | 2023-06-06 | 济南大学 | 一种单导联心电信号辅助诊断方法及诊断终端 |
CN116211315B (zh) * | 2023-04-10 | 2023-08-04 | 济南大学 | 一种单导联心电信号辅助诊断方法及诊断终端 |
Also Published As
Publication number | Publication date |
---|---|
CN111329455A (zh) | 2020-06-26 |
CN114010171A (zh) | 2022-02-08 |
CN114010171B (zh) | 2023-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021184410A2 (zh) | 一种非接触式的心血管健康评估方法 | |
Malik et al. | Sleep-wake classification via quantifying heart rate variability by convolutional neural network | |
Oweis et al. | QRS detection and heart rate variability analysis: A survey | |
Anusha et al. | Electrodermal activity based pre-surgery stress detection using a wrist wearable | |
Sansone et al. | Electrocardiogram pattern recognition and analysis based on artificial neural networks and support vector machines: a review | |
Belgacem et al. | ECG based human authentication using wavelets and random forests | |
Saini et al. | Classification of heart diseases from ECG signals using wavelet transform and kNN classifier | |
Mahajan et al. | Cardiac rhythm classification from a short single lead ECG recording via random forest | |
CN105147248A (zh) | 基于生理信息的抑郁症评估系统及其评估方法 | |
CN107742534A (zh) | 患者存活性预测系统 | |
Henzel et al. | Atrial fibrillation episodes detection based on classification of heart rate derived features | |
Xie et al. | Feature enrichment based convolutional neural network for heartbeat classification from electrocardiogram | |
Akhter et al. | Heart-based biometrics and possible use of heart rate variability in biometric recognition systems | |
Murugappan et al. | Time domain features based sudden cardiac arrest prediction using machine learning algorithms | |
Yu et al. | Automatic detection of atrial fibrillation from ballistocardiogram (BCG) using wavelet features and machine learning | |
Xie et al. | Discrete Biorthogonal Wavelet Transform Based Convolutional Neural Network for Atrial Fibrillation Diagnosis from Electrocardiogram. | |
Rajput et al. | Automated detection of hypertension using wavelet transform and nonlinear techniques with ballistocardiogram signals | |
Pirbhulal et al. | Analysis of efficient biometric index using heart rate variability for remote monitoring of obstructive sleep apnea | |
Amiruddin et al. | Performance evaluation of human identification based on ECG signal | |
Ye et al. | Automatic sleep and wake classifier with heart rate and pulse oximetry: derived dynamic time warping features and logistic model | |
Wu et al. | Stress detection using wearable devices based on transfer learning | |
Kandukuri et al. | Constant Q-transform-based deep learning architecture for detection of obstructive sleep apnea | |
Jose | Review on obstructive sleep apnea detection using ecg signals | |
Belgacem et al. | ECG based human identification using random forests | |
Sundaram et al. | Single lead ECG discrimination between normal sinus rhythm and sleep apnea with intrinsic mode function complexity index using empirical mode decomposition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20925226 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20925226 Country of ref document: EP Kind code of ref document: A2 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 03.07.2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20925226 Country of ref document: EP Kind code of ref document: A2 |